Doxorubicin Hydrochloride-Loaded Nonionic Surfactant Vesicles to Treat Metastatic and Non-Metastatic Breast Cancer

[Image: see text] Doxorubicin hydrochloride (DOX) is currently used to treat orthotropic and metastatic breast cancer. Because of its side effects, the use of DOX in cancer patients is sometimes limited; for this reason, several scientists tried designing drug delivery systems which can improve drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Francesco, Martina, Celia, Christian, Cristiano, Maria Chiara, d’Avanzo, Nicola, Ruozi, Barbara, Mircioiu, Constantin, Cosco, Donato, Di Marzio, Luisa, Fresta, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860091/
https://www.ncbi.nlm.nih.gov/pubmed/33553916
http://dx.doi.org/10.1021/acsomega.0c05350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860091/
https://www.ncbi.nlm.nih.gov/pubmed/33553916
http://dx.doi.org/10.1021/acsomega.0c05350

Ejemplares similares